Representatives of Elon Musk's new federal agency have access to payments and contracting information from the Centers for ...

Representatives from Elon Musk's department are working with the Centers for Medicare and Medicaid Services to identify and address inefficiencies and potential fraud. They have gained access to ...

WASHINGTON (Reuters) -Representatives of Elon Musk's Department of Government Efficiency have been working at the Centers for Medicare and Medicaid Services where they were granted access to agency ...

China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients ...

The last few days have been a rollercoaster for the pharmaceutical industry. Mexico and Canada were bracing themselves for ...

As more research is published about the health benefits associated with GLP-1s, like sleep apnea, heart disease, and ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

CU is participating in the nationwide “Guiding an Improved Dementia Experience” Model, a new health care payment and service delivery model that includes family caregiver support.

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.

Medicaid is a joint federal and state program that provides health care coverage to low-income individuals and families. It ...

Adam Colborn, JD, of AMCP, discussed how President Trump's rescission of several Biden-era executive orders may impact ...